Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
The Lancet Respiratory Medicine (2021) - Comments
doi: 10.1016/s2213-2600(21)00237-x  issn: 2213-2600  pubmed: 34147142  issn: 2213-2619 

Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job R Schippers, Patrick J Smeele, Sara Azhang, Imke H Bartelink, Ahmed A Bayoumy, Pierre M Bet, Wim Boersma, Peter I Bonta, Karin A T Boomars, Lieuwe D J Bos, Job J M H Van Bragt, Gert-Jan Braunstahl, Lucas R Celant, Katrien A B Eger, J J Miranda Geelhoed, Yurika L E Van Glabbeek